Abstract
Many colorectal cancer cells are resistant to the anti-proliferative effects of transforming growth factor-β (TGF-β). TGF-β also acts as paracrine factor from cancer cells on their mesenchymal cells. The aim of this study was to examine the expression of TGF-β and its receptors in human colorectal cancer tissue and determine any relationship with cancer growth. In situ hybridization and Northern blot hybridization detection of TGF-β1, type I and type II receptor mRNA and immunohistochemical staining of TGF-β1 were performed using 11 human colorectal adenomas, 22 colorectal cancers and ten normal colorectal mucosas as control. TGF-β receptor mRNAs were expressed mainly by normal colorectal epithelial cells and adenoma. However, mRNAs for TGF-β receptors were only faintly, if at all, expressed in eight of 22 human colorectal cancers. In addition, intense signals of TGF-β1 mRNA and the protein were detected in all colorectal cancers. TGF-β receptor mRNAs and TGF-β1 protein were also distributed in fibroblasts and endothelial cells in the interstitium. Moreover, Smad 4 protein was translocated to nucleus in primarily cultured adenoma cells, but not in cancer cells after TGF-β stimulation. The escape of human colon cancer from TGF-β -mediated growth inhibition by down-regulation of TGF-β receptors as well as the effects of TGF-β on stroma formation and angiogenesis indicate a possible role for TGF-β in the progression of colon cancer in an intact host.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Attisano, L., Wrana, J. L., López-Casillas, F. & Massagué, J. (1994) TGF-β receptors and actions. BBA 1222: 71–80.
Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M. & Moorghen, M. (1993) TGF-β expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 68: 137–139.
Bae, H. W., Geiser, A. G., Kim, D. H., Chung, M. T., Burmester, J. K., Sporn, M. B., Roberts, A. B. & Kim, S. J. (1995) Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J Biol Chem 270: 29460–29468.
Barnard, J. A., Beauchamp, R. D., Coffey, R. J. & Moses, H. L. (1989) Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc Natl Acad Sci USA 86: 1578–1582.
Barnard, J. A., Lyons, R. M. & Moses, H. L. (1990) The cell biology of transforming growth factor β. Biochem Biophys Acta 1032: 79–87.
Barnard, J. A., Warwick, G. J. & Gold, L. I. (1993) Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology 105: 67–73.
Birchenall-Roberts, M. C., Ruscetti, F. W., Kasper, J., Lee, H. D., Friedman, R., Geiser, A., Sporn, M. B., Roberts, A. B. & Kim, S. J. (1995) Transcriptional regulation of the transforming growth factor β1 promoter by v-src gene products is mediated through the AP-1 complex. Mol Cell Biol 10: 4978–4983.
Cui, W., Fowlis, D. J., Cousins, F. M., Duffie, E., Bryson, S., Balmain, A. & Akhurst, R. J. (1995) Concerted action of TGF-β1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev 9: 945–955.
Date, M., Matsuzaki, K., Matsushita, M., Sakitani, K., Shibano, K., Okajima, A., Yamamoto, C., Ogata, N., Okumura, T., Seki, T., Kubota, Y., Kan, M., McKeehan, W. L. & Inoue, K. (1998) Differential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CC14 administration. J Hepatol 28: 572–581.
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J. P., Angel, P. & Heath, J. K. (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899–1904.
Fráter-Schröder, M., Müller, G., Birchmeier, W. & Böhlen, P. (1986) Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun 137: 295–302.
Franzen, P., ten Dijke, P., Yamashita, H., Schulz, P., Heldin, C-H & Miyazono, K. (1993) Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75: 681–692.
He, W. W., Gustafson, M. L., Hirose, S. & Donahoe, P. K. (1993) Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-β type II receptor family. Den Dyn 196: 133–142.
Heinmark, R. L., Twardzik, D. R. & Schwartz, S. M. (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078–1080.
Hoosein, N. M., McKnight, M. K., Levine, A. E., Mulder, K. M., Childress, K. E., Brattain, D. E. & Brattain, M. G. (1989) Differential sensitivity of subclass of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1 . Exp Cell Res 181: 442–453.
Hutter, R. V. P. & Sobin, L. H. (1986) A universal staging system for cancer of the colon and rectum. Arch Pathol Lab Med 110: 367–368.
Ignotz, R. A. & Massagué, J. (1986) Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337–4345.
Kim, D. H., Chang, J. H., Lee, K. H., Lee, H. Y. & Kim, S. J. (1997) Mechanism of E1A-induced transforming growth factor-β (TGF-β) resistance in mouse keratinocytes involves repression of TGF-β type II transcription. J Biol Chem 272: 688–694.
Koyama, S. & Podolsky, D. K. (1989) Differential expression of transforming growth factors α and β in rat intestinal epithelial cells. J Clin Invest 83: 1768–1773.
Kurokawa, M., Lynch, K. & Podolsky, D. K. (1987) Effects of growth factors on an intestinal epithelial cell line: transforming growth factor β inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun 142: 775–782.
Laiho, M., Saksela, O., Andreasen, P. A. & Keski-Oja, J. (1986) Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblast by transforming growth factor-β. J Cell Biol 103: 2403–2410.
Lin, H. Y., Wang, X-F, Ng-Eaton, E., Weinberg, R. A. & Lodish, H. F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785.
Madri, J. A., Pratt, B. M. & Tucker, A. M. (1988) Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol 106: 1375–1384.
Manning, A. M., Williams, A. C., Game, S. M. & Paraskeva, C. (1991) Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 6: 1471–1476.
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. & Willson, J. K. V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338.
Massagué, J., Hata, A. & Liu, F. (1997) TGF-β signalling through the Smad pathway. Trends Cell Biol 7: 187–192.
Mathew, L. S. & Vale, W. W. (1991) Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65: 973–982.
Matsuzaki, K., Xu, J., Wang, F., McKeehan, W. L., Krummen, L. & Kan, M. (1993) A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenic factor. J Biol Chem 268: 12719–12723.
Matsuzaki, K., Kan, M. & McKeeham, W. L. (1996) Ligand-dependent and independent interactions in assembly of a pentameric transforming growth factor beta receptor complex. In Vitro Cell Dev Biol 32: 345–360.
Muto, T., Bussey, H. J. R. & Morson, B. C. (1975) The evolution of cancer of the colon and rectum. Cancer 36: 2251–2270.
Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Isisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C. H., Miyazono, K. & ten Dijke, P. (1997) TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J 16: 5353–5362.
Oshima, H., Oshima, M., Kobayashi, M., Tsutsumi, M. & Makoto, M. T. (1997) Morphological and molecular processes of polyp formation in ApcΔ716 knockout mice. Cancer Res 57: 1644–1649.
Qian, S. W., Kondaiah, P., Roberts, A. B. & Sporn, M. B. (1990) cDNA cloning PCR of rat transforming growth factor β1 . Nucleic Acids Res 18: 3059
Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F. & Sporn, M. B. (1985) Type β: transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82: 119–123.
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H. & Fauci, A. S. (1986) Transforming growth factor type β rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171.
Serra, R. & Moses, H. L. (1996) Tumor suppressor genes in the TGF-β signaling pathway?. Nature Med 2: 390–391.
Sporn, M. B. & Roberts, A. B. (1988) Peptide growth factors are multifunctional. Nature 332: 217–219.
Sporn, M. B. & Roberts, A. B. (1992) Transforming growth factor-β: recent progress and new challenges. J Cell Biol 119: 1017–1021.
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Michael, F. S. & Makoto, M. T. (1998). Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92: 645–656
ten Dijke, P., Ichijo, H., Franzén, P., Schulz, P., Saras, J., Toyoshima, H., Heldin, C-H & Miyazono, K. (1993) Activin receptor-like kinases: a novel subclass of cell-surface receptors with preedicted serine/threonine kinase activity. Oncogene 8: 2879–2887.
ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K. & Heldin, C-H (1994) Characterization of type I receptors for transforming growth factor-β and activin. Science 204: 101–104.
Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., Imai, Y., Shimomukai, H., Nomura, Y., Matsuda, Y. & Matsuzawa, Y. (1996) High levels of transforming growth factor β1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110: 375–382.
Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K. V., Sun, L. & Brattain, M. G. (1996) Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271: 17366–17371.
Xu, J., Matsuzaki, K., McKeehan, K., Wang, F., Kan, M. & McKeehan, W. L. (1994) Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly (A) addition. Proc Natl Acad Sci USA 91: 7957–7961.
Xu, J., McKeehan, K., Matsuzaki, K. & McKeehan, W. L. (1995) Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 270: 6308–6313.
Zhang, T., Nanney, L. B., Peeler, M. O., Williams, C. S., Lamps, L., Heppner, K. J., DuBois, R. N. & Beauchamp, D. (1997) Decreased transforming growth factor β type II receptor expression in intenstinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. Cancer Res 57: 1638–1643.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Matsushita, M., Matsuzaki, K., Date, M. et al. Down-regulation of TGF-β receptors in human colorectal cancer: implications for cancer development. Br J Cancer 80, 194–205 (1999). https://doi.org/10.1038/sj.bjc.6690339
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690339
Keywords
This article is cited by
-
Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells
BMC Cancer (2016)
-
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF V600E in melanoma
Molecular Cancer (2015)
-
Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells
BMC Cancer (2012)
-
Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas
Journal of Neuro-Oncology (2011)
-
Overexpression of FOXG1 contributes to TGF-β resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer
British Journal of Cancer (2009)